Gilead Sues Teva Over Truvada ANDA
Gilead filed the lawsuit Friday following Teva's filing of an abbreviated new drug application to market a generic version of Truvada, according to a company statement.
“Gilead has full confidence in the strength of its patent position and plans to vigorously defend the intellectual property rights of Truvada,” the company said in a statement....
Already a subscriber? Click here to login